Veracyte (VCYT) Financials: Revenue & Earnings

VCYT price $50.52 +0.24 +0.48%

Ticker
VCYT
Price
$50.52
Change
+0.24 +0.48%
Market cap ?
$4.06B
P/E ?
34.92
Forward P/E ?
26.46
Dividend yield ?
0.00%
Beta ?
1.95
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
65
Value
44
Quality
79
Growth
71

Stocklytics score rationale: value 44, quality 79, growth 71.

Financials

2016201720182019202020212022202320242025
650850007195300092008000120368000117483000219514000296536000361051000445764000517145000

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer…

Fair value

VCYT fair value $57.27. Price $50.52. Price is 12% below fair value.

Above fair value, but less expensive than usual. A smaller premium than on 80% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 74.90M. Growth 14.59%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 80.39M. Net debt -322.92M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare VCYT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—0.41—147.16M
2026-07-300.540.41150.32M144.59M
2026-05-050.520.34139.07M130.36M
2026-02-250.530.41140.64M135.79M
2025-11-040.510.32131.87M124.97M
2025-08-060.440.31130.20M121.04M
2025-05-070.310.12114.50M111.27M
2025-02-240.070.10118.63M116.70M
2024-11-060.190.03115.86M109.82M
2024-08-060.07-0.03114.40M100.27M
2024-05-07-0.02-0.1696.84M93.35M
2024-02-22-0.39-0.0798.20M91.97M
2023-11-07-0.41-0.1690.11M84.36M
2023-08-08-0.12-0.1590.32M83.05M
2023-05-04-0.11-0.1382.42M75.80M
2023-02-22-0.05-0.1580.30M73.94M
2022-11-02-0.12-0.2575.59M66.41M
2022-08-02-0.13-0.2272.90M68.08M
2022-05-03-0.20-0.2467.78M61.92M
2022-02-28-0.15-0.1667.34M62.52M
2021-11-09-0.13-0.1460.37M53.64M
2021-07-29-0.13-0.2555.10M55.10M
2021-05-10-0.11-0.1236.70M32.03M
2021-02-17-0.14-0.1134.54M31.75M
2020-11-02-0.08-0.2131.12M81.69M
2020-07-30-0.22-0.2420.70M22.59M
2020-05-06-0.24-0.2031.12M25.93M
2020-02-25-0.15-0.0729.73M23.65M
2019-10-22-0.02-0.0730.97M108.41M
2019-07-30-0.05-0.1030.14M60.27M
2019-04-30-0.05-0.1029.53M59.06M
2019-02-25-0.08-0.1525.75M48.28M
2018-10-29-0.12-0.2423.47M46.93M
2018-07-23-0.18-0.2722.75M34.13M
2018-05-01-0.27-0.2520.04M18.56M
2018-02-27-0.24-0.2019.60M16.33M
2017-11-06-0.21-0.2317.52M19.19M
2017-07-31-0.22-0.2518.41M20.92M
2017-05-03-0.24-0.2516.43M17.12M
2017-03-01-0.14-0.2618.26M33.91M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-19Bhanji MunaSell1.86K$43.7081.46K
2026-09-21Leite JohnSell4.01K$40.00160.60K
2026-09-14Holstein JensSell5.00K$40.95204.75K
2026-09-04Febbo Phillip G.Sell10.40K$42.89446.30K
2026-09-04Febbo Phillip G.Sell2.71K$43.66118.11K
2026-09-04Chambers RebeccaSell2.48K$42.81106.03K
2026-09-04Chambers RebeccaSell1.18K$43.7151.36K
2026-09-04McGuire AnnieSell2.15K$42.7992.17K
2026-09-04McGuire AnnieSell1.10K$43.6748.04K
2026-09-02Wygant JonathanSell1.36K$44.8861.08K
2026-09-02Leite JohnSell3.96K$44.88177.77K
2026-09-02Febbo Phillip G.Sell3.64K$44.88163.32K
2026-09-02Chambers RebeccaSell3.60K$44.88161.70K
2026-09-02McGuire AnnieSell3.21K$44.88144.29K
2026-09-02Stapley MarcSell8.78K$44.88394.14K
2026-09-01Bhanji MunaSell1.86K$42.9780.10K
2026-06-18EASTHAM KARINSell3.20K$52.78168.91K
2026-06-18EASTHAM KARINSell529$53.5528.33K
2026-06-11EASTHAM KARINBuy5.27K——
2026-06-11JONES EVAN/ FABuy5.27K——
2026-06-11Shafer David BrentBuy5.27K——
2026-06-11Barr EliavBuy5.27K——
2026-06-11EPSTEIN ROBERT SBuy5.27K——
2026-06-11Holstein JensBuy5.27K——
2026-06-11Bhanji MunaBuy5.27K——
2026-06-11Miller Thomas F.Buy5.27K——
2026-06-04McGuire AnnieSell1.40K$49.3169.03K
2026-06-04McGuire AnnieSell1.78K$50.1289.01K
2026-06-04Chambers RebeccaSell1.60K$49.2878.85K
2026-06-04Chambers RebeccaSell1.96K$50.0998.23K
2026-06-04Stapley MarcBuy138.05K$36.605.05M
2026-06-04Stapley MarcSell138.05K$50.126.92M
2026-06-04Stapley MarcSell138.05K$36.605.05M
2026-06-04Leite JohnSell13.97K$50.07699.73K
2026-06-02McGuire AnnieSell3.29K$47.80157.36K
2026-06-02Wygant JonathanSell1.36K$47.8065.06K
2026-06-02Chambers RebeccaSell3.69K$47.80176.53K
2026-06-02Febbo Phillip G.Sell3.73K$47.80178.29K
2026-06-02Stapley MarcSell9.01K$47.80430.77K
2026-06-02Leite JohnSell4.06K$47.80194.02K
2026-05-22Wygant JonathanBuy24.00K$24.80595.20K
2026-05-22Wygant JonathanSell24.00K$45.401.09M
2026-05-22Wygant JonathanSell24.00K$24.80595.20K
2026-05-20EPSTEIN ROBERT SSell10.00K$44.01440.13K
2026-05-06McGuire AnnieSell5.10K$38.05194.13K
2026-05-06McGuire AnnieSell5.10K$40.00204.08K
2026-04-10Haas Kevin RichardBuy44.22K——
2026-03-24Haas Kevin RichardOther0——
2026-03-06Wygant JonathanBuy10.53K——
2026-03-06McGuire AnnieBuy26.31K——
2026-03-06McGuire AnnieBuy32.89K——
2026-03-06Febbo Phillip G.Buy6.58K——
2026-03-06Febbo Phillip G.Buy29.60K——
2026-03-06Leite JohnBuy6.58K——
2026-03-06Leite JohnBuy36.18K——
2026-03-06Stapley MarcBuy92.10K——
2026-03-06Chambers RebeccaBuy13.16K——
2026-03-06Chambers RebeccaBuy36.18K——
2026-03-04Chambers RebeccaSell4.40K$35.55156.41K
2026-03-04Chambers RebeccaSell13.94K$36.33506.46K
2026-03-04Stapley MarcSell19.24K$35.56684.23K
2026-03-04Stapley MarcSell26.28K$36.28953.37K
2026-03-04Leite JohnSell5.26K$35.19185.08K
2026-03-04McGuire AnnieSell4.99K$35.29176.26K
2026-03-04McGuire AnnieSell1.66K$36.3460.47K
2026-03-02McGuire AnnieSell6.90K$36.01248.54K
2026-03-02Wygant JonathanSell3.01K$36.01108.25K
2026-03-02Chambers RebeccaSell7.23K$36.01260.50K
2026-03-02Leite JohnSell7.52K$36.01270.69K
2026-03-02Febbo Phillip G.Sell6.04K$36.01217.32K
2026-03-02Febbo Phillip G.Sell13.43K$36.16485.43K
2026-03-02Stapley MarcSell19.45K$36.01700.57K
2026-02-26Leite JohnBuy47.15K——
2026-02-26Leite JohnSell8.90K$38.75345.07K
2026-02-26Stapley MarcBuy139.07K——
2026-02-26Stapley MarcSell35.84K$38.751.39M
2026-02-26Chambers RebeccaBuy59.32K——
2026-02-26Chambers RebeccaSell12.05K$38.75466.90K
2026-02-26Febbo Phillip G.Buy71.81K——
2026-02-26Febbo Phillip G.Sell24.49K$38.75948.83K
2026-02-26McGuire AnnieBuy51.00K——
2026-02-26McGuire AnnieSell10.87K$38.75421.10K
2025-12-16McGuire AnnieSell10.64K$43.13458.84K
2025-12-16McGuire AnnieSell100$43.684.37K
2025-12-05EASTHAM KARINBuy10.00K$7.6076.00K
2025-12-05EASTHAM KARINSell6.39K$44.52284.57K
2025-12-05EASTHAM KARINBuy10.00K$7.9479.40K
2025-12-05EASTHAM KARINSell12.81K$45.84587.08K
2025-12-05EASTHAM KARINSell800$46.5937.27K
2025-12-05EASTHAM KARINSell10.00K$7.9479.40K
2025-12-05EASTHAM KARINSell10.00K$7.6076.00K
2025-12-04McGuire AnnieSell720$47.1033.91K
2025-12-04McGuire AnnieSell702$47.5133.35K
2025-12-04Chambers RebeccaSell8.54K$46.61397.95K
2025-12-04Chambers RebeccaSell4.74K$47.25224.01K
2025-12-04Stapley MarcSell4.45K$46.90208.61K
2025-12-04Stapley MarcSell3.22K$47.35152.46K
2025-12-04Leite JohnSell1.28K$47.5160.72K
2025-12-02Febbo Phillip G.Sell2.96K$46.16136.40K
2025-12-02McGuire AnnieSell3.05K$46.16140.88K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 379, holders +39 vs prior quarter. Ownership 113.09%.

HolderSharesChangeChange %Value
BLACKROCK, INC.13.49M313.82K+2.38%792.06M
FMR LLC7.70M-61.10K-0.79%452.38M
ARTISAN PARTNERS LIMITED PARTNERSHIP5.54M42.03K+0.76%325.27M
VANGUARD PORTFOLIO MANAGEMENT LLC4.72M271.46K+6.11%276.98M
STATE STREET CORP4.70M-345.46K-6.85%275.95M
VANGUARD CAPITAL MANAGEMENT LLC3.59M61.69K+1.75%211.07M
DIMENSIONAL FUND ADVISORS LP2.83M-54.57K-1.89%166.01M
FIRST TRUST ADVISORS LP2.51M390.86K+18.46%147.29M
ARK INVESTMENT MANAGEMENT LLC2.30M-757.87K-24.82%134.84M
WELLINGTON MANAGEMENT GROUP LLP2.27M-284.12K-11.11%133.56M
GEODE CAPITAL MANAGEMENT, LLC2.10M146.90K+7.51%123.59M
GOLDMAN SACHS GROUP INC1.64M366.65K+28.73%96.49M
FULLER & THALER ASSET MANAGEMENT, INC.1.51M95.39K+6.74%88.67M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC1.43M441.91K+44.65%84.08M
GW&K INVESTMENT MANAGEMENT, LLC1.42M-20.78K-1.45%83.19M
MORGAN STANLEY1.19M393.99K+49.38%69.99M
BANK OF AMERICA CORP /DE/1.10M-346.62K-23.92%64.74M
DRIEHAUS CAPITAL MANAGEMENT LLC1.05M1.05MNew61.42M
NORTHERN TRUST CORP996.15K66.65K+7.17%58.50M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.939.98K939.98KNew55.21M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC939.98K16.41K+1.78%55.21M
OBERWEIS ASSET MANAGEMENT INC/877.73K37.90K+4.51%51.55M
LEGAL & GENERAL GROUP PLC858.14K-39.03K-4.35%50.40M
SUMITOMO MITSUI TRUST GROUP, INC.768.95K-286.71K-27.16%45.16M
AMOVA ASSET MANAGEMENT AMERICAS, INC.768.95K-276.10K-26.42%45.12M

Earnings and financials

Veracyte, Inc. (VCYT) trades at $50.52, with a market cap of $4.06B and a trailing P/E of 34.92. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
650850007195300092008000120368000117483000219514000296536000361051000445764000517145000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Veracyte (VCYT) Financials: Revenue & Earnings

VCYT$50.52+0.24 +0.48%

$4.06B

Market Cap

34.92

P/E

26.46

Forward P/E

65

Score

Price History